Skip to main content
  1. Home
  2. Emerging Tech
  3. News

Researchers use fungi to develop space drugs on International Space Station

Add as a preferred source on Google

When people think of fungi, they often think of mushrooms or mold, but there is so much more to this diverse group of organisms. Not only are fungi used to make beer, wine and bread, but they are also vital ingredients in some of the most popular and successful medications ever developed. Their ability to create natural products with medicinal properties is going to be tested again — this time on the International Space Station.

As part of the NASA Micro-10 project, the Wang Group of the University of Southern California, along with the NASA Space Biology Program and CASIS, is preparing to send four four different strains of Aspergillus nidulans, a standard pharmaceutical research fungi, to the International Space Station. The fungi will be included in the payload being sent to the station on the upcoming SpaceX CRS-8 mission, which is expected to launch on April 8.

Recommended Videos

“This is the first project where we see an intersection between pharmaceutical science and space exploration,” said principal investigator and USC pharmacologist Clay Wang.

The scientists on board the space station will cultivate the fungi and study the effects of both microgravity and high radiation on the fungi’s natural product production. The crew will grow the fungi at a tropical 98.6 degrees Fahrenheit for one week and then store the specimens in the freezer until they are sent back to Earth in May for analysis. Growth and natural product production from the space-based fungi will be compared to control samples of the fungi that were grown at the same time on Earth.

Related: The International Space Station just turned 15 years old

On Earth, A. nidulans is used to produce Anidulafungin, an antifungal drug used to treat invasive fungal infections such as candidiasis. The team hopes the extreme conditions of the space environment will stimulate A. nidulans to develop new biosynthetic pathways which could lead to the production of novel drugs capable of treating diseases such as cancer and Alzheimer’s, among others.

Researchers also hope that a successful trial could open the door to future space-based pharmaceutical experiments and the discovery of even more new medicines. These experiments may prove beneficial to our health and well-being on Earth and on future Mars missions, which could rely on these organisms to produce drugs during the lengthy trip to the red planet.

Kelly Hodgkins
Kelly's been writing online for ten years, working at Gizmodo, TUAW, and BGR among others. Living near the White Mountains of…
Google’s new AI gives robots better balance, smarter hands, and teamwork capabilities
Google just made robots a lot less clumsy and a lot more helpful.
Gemini robotics 2.0

Google DeepMind just brought sci-fi robots closer to reality, and it is very exciting. Building on its original Gemini Robotics model, the company has introduced Gemini Robotics 2, an AI system designed to help robots think, move, and even work together. Unlike most robots today, which rely on pre-programmed routines or someone controlling them remotely, this new system lets robots figure things out on their own when situations get unpredictable.

Can robots finally handle whole-body tasks?

Read more
Remember Samsung’s Ballie home robot? It may finally be inching closer to reality
Leaked app wireframes give the strongest hint yet that Samsung's Ballie home robot, first shown at CES 2020, might still be headed toward an actual release.
Samsung Ballie robot in a room next to a dog feeder.

Samsung's rolling home robot has been the industry's longest-running "will it ever actually ship" joke, and I'll admit I'd mostly given up on it. Now, there's finally a glimmer of hope.

Samsung first unveiled Ballie as a concept at CES 2020. Then, it showed it as a significantly upgraded version four years later. However, the company never confirmed a release date or committed to releasing it at all. 

Read more
Polar is yet another AI browser, but it goes beyond just automating the mundane web chores
Polar wants to turn your browser into an AI-powered productivity tool
Polar AI browser

The AI browser race is entering a new phase. After spending much of 2025 trying to reinvent web search with built-in chatbots, startups are increasingly shifting their attention toward browser agents that can automate repetitive work instead of simply answering questions. The latest company to embrace that transition is Polar, a startup founded by former Perplexity engineer Kevin Zhang, which has raised $5.7 million in seed funding led by Madrona.

Unlike the first generation of AI browsers that targeted everyday consumers, Polar is designed specifically for knowledge workers. Its premise is straightforward: instead of replacing Google Search, the browser aims to eliminate repetitive tasks that professionals perform across dozens of browser tabs every day.

Read more